Sculptor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-155,300
Closed -$7.95M – 759
2014
Q3
$7.95M Sell
155,300
-63,700
-29% -$3.18M 0.02% 427
2014
Q2
$10.6M Sell
219,000
-111,100
-34% -$5.47M 0.03% 389
2014
Q1
$17.1M Sell
330,100
-100
-0% -$5.32K 0.06% 291
2013
Q4
$17.6M Sell
330,200
-447,000
-58% -$22.8M 0.05% 362
2013
Q3
$36M Buy
777,200
+95,700
+14% +$4.2M 0.1% 256
2013
Q2
$30.5M Buy
+681,500
New +$29.6M 0.1% 260

Other funds holding BMY

Sculptor Capital's BMY Position: Q3 2022 in Review

Sculptor Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 108,809 shares — an estimated $8.38M sold.

Sculptor Capital first reported a position in BMY in Q4 2013 and held it in 8 quarters. The position peaked at $77.2M in Q4 2016. 2,472 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Sculptor Capital reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 108,809 Bristol-Myers Squibb shares in Q3 2022, an estimated $8.38M.
  • Sculptor Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 8 quarters.
  • Sculptor Capital's Bristol-Myers Squibb position peaked at $77.2M in Q4 2016.
  • 2,472 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.